The MTD Group is proud to announce that its “G34 pen needle” device for insulin injection has received the highest award in the #LifeScienceExcellenceAwards 2022
MTD Group – a global leader in medical devices– today announced the FDA clearance obtained by its affiliate Pikdare S.p.A. for DropSafeTM SicuraTM passive safety needle
Lugano, 20th September 2022 – Medical Technology and Devices appointed Charles Bouaziz as new Chief Executive Officer of the Group. Charles is an industry veteran with
MTD Exchange is a grassroots community program born with the objective to bring leaders, healthcare professionals and various stakeholders together to discuss and share experience
Lugano, 21st May 2021 – In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of
The World Health Organization estimates that there are over 35 million health workers worldwide. These HCPs face an increased risk of infection with blood-borne pathogens
Going against the tide, investing in #technology #innovation and creating new alliances, recruiting to find new skills, strengthening links with suppliers and rethinking the range
Through our brands, we constantly work to strengthen our partnership with the pharmacy stores not only by serving them with the broadest selfcare product range,
We know that, as we move into the future, we are expected to demonstrate the integration of diabetes clinical management, education, prevention, and support. Last
But MTD Group, even in a scenario of unforeseen events, has managed to distinguish itself, ensuring constant support to people and #healthcare systems, and achieving a remarkable
